Literature DB >> 4965244

A quantitative comparison of the faecal flora of patients with ulcerative colitis and that of normal persons.

E M Cooke.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4965244     DOI: 10.1002/path.1700940225

Source DB:  PubMed          Journal:  J Pathol Bacteriol        ISSN: 0368-3494


× No keyword cloud information.
  13 in total

1.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors: 
Journal:  Am J Dig Dis       Date:  1975-06

Review 2.  Hydrogen sulphide: a bacterial toxin in ulcerative colitis?

Authors:  M C Pitcher; J H Cummings
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

3.  Adhesive Escherichia coli in inflammatory bowel disease and infective diarrhoea.

Authors:  D A Burke; A T Axon
Journal:  BMJ       Date:  1988-07-09

Review 4.  Inflammatory bowel disease as a model for translating the microbiome.

Authors:  Curtis Huttenhower; Aleksandar D Kostic; Ramnik J Xavier
Journal:  Immunity       Date:  2014-06-19       Impact factor: 31.745

5.  Faecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine.

Authors:  E M Cooke
Journal:  Gut       Date:  1969-07       Impact factor: 23.059

6.  Proceedings: Etiology of ulcerative colitis.

Authors:  D P Jewell
Journal:  Proc R Soc Med       Date:  1973-10

7.  Escherichia coli and ulcerative colitis.

Authors:  E M Cooke
Journal:  Proc R Soc Med       Date:  1969-05

8.  Colonic bacterial proteases to IgA1 and sIgA in patients with ulcerative colitis.

Authors:  G D Barr; M J Hudson; J D Priddle; D P Jewell
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

9.  Ulcerative colitis and Escherichia coli with adhesive properties.

Authors:  D A Burke; A T Axon
Journal:  J Clin Pathol       Date:  1987-07       Impact factor: 3.411

10.  Changes in bacterial enzymes and PCR profiles of fecal bacteria from a patient with ulcerative colitis before and after antimicrobial treatments.

Authors:  F Rafii; J G Ruseler-Van Embden; L M van Lieshout
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.